Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies. The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.
A new non-invasive prenatal test (NIPT) called NIFS can screen for thousands of severe genetic diseases by analyzing fetal DNA from maternal blood, with over 97% accuracy. Developed by researchers from the Broad Institute, this technology promises to reduce reliance on invasive procedures like amniocentesis, though concerns about over-screening and parental anxiety have been raised.
Scientists have developed a new non-invasive maternal blood test, NIFS, capable of detecting thousands of serious genetic conditions in a fetus. This advanced sequencing technique identifies fetal DNA fragments in the mother's blood, potentially replacing invasive procedures like amniocentesis and offering earlier diagnosis for a wider range of disorders.
Tens of thousands more black men aged 45-74 in the UK will be invited for prostate cancer checks as part of an £18 million government-funded trial. The move aims to find better testing methods for the disease, which disproportionately affects black men.
MiraOne, a comprehensive blood test founded by Dr. Nickhil Jakatdar, Dr. Nickhil Phadke, and Mr. Abhinav Kejriwal, combines blood markers, genetic insights, and medicine-response analysis into a single report. It aims to provide personalized and actionable wellness recommendations, addressing the limitations of traditional medicine and empowering individuals to make informed health decisions.
MiraOne, a comprehensive blood test, launched in Mumbai, provides a single report integrating blood markers, DNA analysis, and pharmacogenomics to offer personalized health insights, aiming to transform India's healthcare approach.
Ukrainian swimmer Andriy Govorov details his first experience with performance-enhancing drugs for the controversial Enhanced Games in Las Vegas, where athletes use banned substances for financial rewards. The event faces strong opposition from anti-doping agencies.
Researchers believe a simple blood test measuring pTau181 protein, combined with memory complaints, can detect Alzheimer's up to 30 years before diagnosis. This early detection could allow for preventative lifestyle changes or treatments to slow disease progression.
Hematologist Rodolfo Cameo stated that people with high anxiety should get a vitamin B12 test, as a deficiency can mimic anxiety symptoms and lead to depression, dementia, and psychosis.
A comprehensive review of six trials with nearly 800,000 men shows prostate cancer screening reduces deaths by 2 per 1,000 men screened, but also leads to unnecessary treatments and complications, highlighting the need for informed patient decisions.
The South Australian government has announced that pregnant women will be able to access free omega-3 blood tests from next month.
The father of Sandipan Dhar, who died after not receiving a blood test at Joondalup Health Campus, says there is still a lack of accountability over his son's death.
Anthropic has unveiled 'Claude Mythos', an AI model with advanced cybersecurity and hacking capabilities. While being shared with tech giants to patch vulnerabilities, the model's potential for misuse and the lack of regulation raise alarms about global digital infrastructure security.
